Table of Contents
Archives of Craniofacial Surgery (Arch Craniofac Surg, ACFS) is the official journal of the Korean Cleft Palate-Craniofacial Association.
Manuscripts on any aspect of craniofacial surgery-clinical or laboratory research, operative procedures, comprehensive reviews-as well as selected case reports, ideas and innovations, letters and correspondence are invited for publications.
This journal will be published six times per year (February 20th, April 20th, June 20th, August 20th, October 20th, and December 20th). Editorial committee makes decisions concerning editing, revision, acceptance or rejection of any manuscripts. Editing may include shortening an article, reducing the number of illustrations or tables or changing the paper’s format.
SUBMISSION OF MANUSCRIPTS
All manuscripts should be submitted online via the journal’s website (http://submit.e-acfs.org) by the corresponding author.
Submission instructions are available at the website. All articles submitted to the journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication. Send all correspondence regarding submitted manuscripts to:
The Editing Committee of the Korean Cleft Palate-Craniofacial Association
Department of Plastic and Reconstructive Surgery
Chonnam National University Medical School, 42 Jebong-ro,
Dong-gu, Gwangju 61469, Korea
Tel: +82-62-220-6354 Fax: +82-62-220-6357
Hana Bank: 224-910051-55404 (Depositor: The Editing Committee of the Korean Cleft Palate-Craniofacial Association)
RESEARCH AND PUBLICATION ETHICS
The Journal adheres to the guidelines and best practices published by professional organizations, including ecommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf) from ICMJE and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; http://doaj.org/bestpractice/).
Registration of Clinical Trial Research
It is recommended that any research that deals with a clinical trial be registered with a primary national clinical trial registration site, such as http://cris.cdc.go.kr/, or other sites accredited by the WHO as listed at http://www.who.int/ictrp/en/.
Conflict of Interest Statement
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
Statement of Informed Consent
Copies of written informed consent and institutional review board (IRB) approval for clinical research should be kept. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct. In addition, for studies conducted with human subjects, the method by which informed consent was obtained from the participants (i.e., verbal or written) also needs to be stated in the Methods section.
Patient Photographic and Videographic Consent
Patients introduced in the manuscripts should be informed and aware that their photographs, videotapes, and other images (imaging records) will be released by the authors, and the authors should attach the Authorization and Release Form available at the ACFS website (http://submit.e-acfs.org/) including each patient’s signature.
Statement of Human and Animal Rights
Clinical research should be done in accordance with the Ethical Principles for Medical Research Involving Human Subjects, as outlined in the Helsinki Declaration of 1975 (revised 2008) (available from: http://www.wma.net/en/30publications/10policies/b3/). Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. For publication, the human subjects’ identifiable information, such as the patients' names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. For animal subjects, the research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.
Authorship credit should be based on 1) substantial contributions to conception and 2) design, acquisition of data, or analysis and 3) approval of the version to be published. Authors should meet Enacted: March 1, 1995 1st revision: March 1, 2009 2nd revision: December 1, 2011 these 3 conditions. If the number of authors is greater than six, there should be a list of each author’s role for the submitted paper. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors on the paper. Copyright assignment must be completed by every author.
Originality and Duplicate Publication
All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. The duplication will be checked through crosscheck (https://app.ithenticate.com/) or eTBLAST (http://etest.vbi.vt.edu/etblast3/) before submission. If duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutes will be informed. There will also be penalties for the authors. A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, illustrations, and tables.
It is possible to republish manuscripts if the manuscripts satisfy the conditions of secondary publication of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
PEER REVIEW PROCESS
All manuscripts will be evaluated by three peer reviewers who are selected by the editors. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 3 weeks after the agreement of review by the reviewers, and the reviewers’ comments will then be sent to the corresponding authors. Revised manuscripts must be submitted online by the corresponding author. The corresponding author must indicate the alterations that have been made in response to the referees’ comments item by item in a response note and the submitted original file with tracing. Failure to resubmit the revised manuscript within 8 weeks of the editorial decision is regarded as a withdrawal. The editorial office should be notified if additional time is needed or if an author chooses not to submit a revision. The editorial committee makes decisions concerning editing, revision, and acceptance or rejection, and editing may include shortening an article, reducing the number of illustrations or tables, or changing the paper’s format or the order of the manuscript. Authors can track the progress of a manuscript on the journal’s website. Articles that are accepted for publication are moved from the “Manuscripts Accepted” to the “Manuscripts in Publication” section of the journal’s website.
COPYRIGHTS AND CREATIVE COMMONS ATTRIBUTION LICENSE
The manuscript, when published, will become the property of the journal. All published papers become the ermanent property of the Korean Cleft Palate-Craniofacial Association and must not be published elsewhere without written permission.
Copyrights of all published materials are owned by the Korean Cleft Palate-Craniofacial Association. They also follow the Creative Commons Attribution Non-Commercial License available from: http://creativecommons.org/licenses/by-nc/4.0/.
ACFS publishes editorial, review articles, original articles, case reports, ideas and innovations.
1. Editorials are invited perspectives on an area of craniofacial surgery, dealing with very active fields of research, current surgical interests, fresh insights, and debates.
2. Review articles provide a concise review of a subject of importance to plastic surgery researchers written by an invited expert in craniofacial surgery.
3. Original articles are papers reporting the results of basic and clinical investigations that are sufficiently well documented to be acceptable to critical readers.
4. Case reports/ideas and innovations deal with clinical cases of surgical interest or innovation.
5. Continuing medical education describes the recent approaches and developments of craniofacial surgery for practitioners or trainees.
6. Book reviews may be published when receiving new books to be introduced to plastic and reconstructive surgeons. Authors or publishing companies are welcomed to submit their recent published books to the editorial oce.
7. Letters are short original research articles on issues important to researchers
8. Brief notes are short reports on a case or surgical tips.
9. Communications are interesting and instructive information for readers.
1. The main document with the manuscript text and tables should be prepared with in an MS Word format (2007 or later version, Times New Roman in shape of characters) in English.
2. The manuscript should be written in 10-point font with double line spacing on A4 sized (21.0×29.7cm) paper with 2.5cm margins on the top, bottom, right, and left.
3. There should be no mention of the institution where the work was carried out, especially in the Abstract and Methods section. If the institution should be inserted, include it afer acceptance of an article.
4. The use of acronyms and abbreviations is discouraged and should be kept to a minimum. When used, they are to be defined where fist used, followed by the acronym or abbreviation in parentheses.
5. Drug and chemical names should be stated in standard chemical or generic nomenclature. Generic and brand name of medicine: for medicine, use generic names. If a brand name should be used, insert it in parentheses after the generic name.
6. Units of measure should be presented according to the International System (SI) of units. All units must be preceded by one space except percentage(%) and temperature(°C).
7. Descriptions of genes or related structures in a manuscript should include the names and official symbols provided by the US National Center for Biotechnology Information (NCBI) or the HUGO Gene Nomenclature Committee.
8. Statistical expression: mean and standard deviation should be described as mean±SD, and mean and standard error as mean±SE. p-values should be described as p<0.05 or p=0.003.
Reporting Guidelines for Specific Study Designs
For the specific study design, such as randomized control studies, studies of diagnostic accuracy, meta-analyses, observational studies, and non-randomized studies, it is recommended that the authors follow the reporting guidelines listed in the following table.
Manuscripts will not be acceptable for publication unless they meet the following editorial requirements. Manuscripts must include 1) Title page, 2) Structured abstract and Keywords, 3) Main text (Introduction, Methods, Results, Discussion, conclusion), 4) Conflict of Interest, 5) References, 6) Tables, and 7) Figure legends. Each component should begin on a new page in the following sequence. Manuscripts on original work should contain a maximum of 3,000 words for the contents of the text, 20 figure pieces, and 40 references.
1) Title Page
A running title (no more than 40 characters in length), manuscript title, and each author’s full name and affiliation including the name of the country, should be provided.
For a multicenter study, indicate each individual’s affiliation using a superscript Arabic number (1, 2, 3…).
All persons designated as authors should be qualified for authorship. Each author should have participated sufficiently in the work to take public responsibility- Instruction for Authors for the content.
A 'corresponding author' for reprints should be indicated, and full contact information (including address, telephone number, fax number, and e-mail) should be provided.
Any financial disclosure or support (grant number, institution, and location), thesis article (title and reviewers' page), acknowledgments (persons who have contributed intellectually to the paper but whose contributions do not justify authorship may be named and their function or contribution described, e.g., "scientific adviser," "data collection," or "participation in clinical trial." all sources of funding applicable to the study should be stated here explicitly), and presentation history (name of the meeting and date) at a meeting should be included if relevant.
2) Abstract and Keywords
The abstract should contain the following components in the order listed: Background, Methods, Results, and Conclusion. It should not exceed 300 words. A list of keywords, between 3 and 10, should be included at the end of the abstract in alphabetical order. The first letter of a keyword should be capitalized (e.g., Free tissue flaps / Mammaplasty / Surgery). The authors should use terms from the MeSH database (https://www.ncbi.nlm.nih.gov/mesh).
3) Main Text
Introduction: The purpose of the investigation, including relevant background information, should be briefly described.
Methods: The research plan, the materials (or subjects), and the methods used should be described, in that order. How the disease was confirmed and how subjectivity in observations was controlled should be explained in detail. When the experimental methodology is the main issue of the paper, the process should be described in detail so as to recreate the experiment as closely as possible. The sources of the apparatus or reagents used should be given along with the source location (name of company, city, and country).
Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance. If relevant, information on the IRB approval and informed consent should be included. Methods of statistical analysis and criteria for statistical significance should be described.
Results: The results should be presented in logical sequence in the text, tables, and illustrations. The text should not repeat all the data in the tables or figures, but describe important points and trends.
Discussion: Observations pertaining to the results of research and other related materials should be interpreted for your readers. New and important observations should be emphasized; the contents in the Introduction or Results should not be simply repeated. The meaning of the observed opinion, along with its limits, should be explained, and within the limits of the research results, the conclusion should be connected to the purpose of the research.
4) Conflict of Interest
The corresponding author of an article is asked to inform the editor of the authors’ potential conflicts of interest possibly influencing their interpretation of data. A potential conflict of interest should be disclosed in the manuscript even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may be financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems (e.g., employment/affiliation, grants or funding, consultancies, stockownership or options, royalties, or patents filed, received, or pending).
5) ORCID (Open Researcher and Contributor ID)
Authors are recommended to provide an ORCID. To obtain an ORCID, authors should register in the ORCID website: https://orcid.org. Registration is free to every researcher in the world.
References should be obviously related to the content of the submitted paper and should not exceed 40. References should be numbered consecutively in the order in which they are first mentioned in the text.
Each reference should be cited as,[1,4], or[1-3], at the end of the related sentence in the text. The abbreviated journal title should be used according to the List of Journals Indexed for MEDLINE (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals) and the List of KoreaMed Journals(http://www.koreamed.org/JournalBrowser.php).
If there are six or fewer authors in a reference, then all the names of the authors should be listed. If the number of authors is greater than six, list the initial six authors, and then abbreviate the rest of the authors with ‘et al.’. A comma, not and, should be used before the last author’s name. Unpublished observations and personal communication should not be used as references, although references to written, not oral communication may be inserted (in parentheses) in the text.
Abstracts published in a citable journal may be cited. To cite a paper accepted but not yet published, state the paper’s DOI number. References must be verified by the author (s) against the original documents. Other types of references not described below should follow Citing medicine: The NLM style guide for authors, editors, and publishers (http://www.ncbi.nlm.nih.gov/books/NBK7256/).
Sample references are given below:
1.Choi WK, Kang DH, Oh SA. Anatomical reconstruction of the medial orbital wall fracture. Arch Craniofac Surg 2012;13:29-35.
2. Jacobs JM, Dec W, Levine JP, McCarthy JG, Weimer K, Moore K, Ceradini DJ. Best face forward: virtual modeling and custom device fabrication to optimize craniofacial vascularized composite allotransplantation. Plast Reconstr Surg 2012 Dec 29 [Epub]. http://dx.doi.org/10.1097/PRS.0b013e31 82729ef0.
3. Weinzweig J. Plastic surgery secrets plus. Philadelphia: Mosby Elsevier; 2010.
4. Thorne CH. Otoplasty and ear reconstruction. In: Thorne CH, Bartlett SP, Beasley RW, Aston SJ, Gurtner GC, Spear SL, editors. Grabb and Smith's plastic surgery. 6th ed. New York: Lippincott Williams & Wilkins; 2006. p. 302-24.
5. American Society of Plastic Surgeons. 2010 plastic surgery procedural statistics [Internet]. Arlington Heights, IL: The Society; c2012 [cited 2012 Nov 1]. Available from: http://www.plasticsurgery.org/News-and-Resources/Statistics.html.
Tables should be typed double-spaced on separate pages within manuscript, and they should be titled and numbered in Arabic numerals in the order of their first citation in the text.
Each column should be given a short heading. Only the first letter of the first word in each row and column should be capital letters. If numerical measurements are given, the unit of measurement should be included in the column heading. The statistical significance of observed differences in the data should be indicated by the appropriate statistical analysis.
All nonstandard abbreviations should be defined in footnotes. For special remarks, lower case letters in superscripts a), b), c), d), e). should be used.
|Table 1. Treatment modality
|Wide excision + RT
|Wide excision + skin graft
Values are presented as number (%).
TRAM, transverse rectus abdominis myocutaneous; LR, local recurrence; MRM, modified radical mastectomy; RT, radiotherapy.
a) Chi square test.
Each figure should be submitted in a separate file, at a resolution of more than 600 dpi for photos/color images and 1,200 dpi for line art.
Lettering and identifying marks should be clear, and the type size should be consistent on each figure. Capital letters should be used for specific areas of identification in a figure
Symbols, lettering, and numbering should be distinctly recognizable so that when the figure is reduced for publication each item will still be legible.
Figure legends should not be included in the same file as the figure, but placed instead on a page at the end of the manuscript.
The figures should be numbered in the form Fig. 1, Fig. 2, and Fig. 3. Only the first letter of the first word in the title and data should be capital letters. Related figures should be combined into one figure, with each subfigure denoted by the letters, A, B, C, and so on, following the Arabic number of the main figure(ex: Fig. 1A, Fig. 1B, C). Do not label in the corner using capital letters on each figure.
The illustrations of pathological tissue should state clearly the type of stain (ex: H&E, ×400), and the main contents should be marked by signs or arrows on the picture.
The Editorial Committee may request that hand-drawn illustrations be redrawn by a graphic designer.
Editorials are invited by the editor and should be commentaries on articles published recently in the ACFS. Editorial topics could include active areas of research, fresh insights, and debates in all fields of plastic and reconstructive surgery. Editorials should not exceed 2,000 words, excluding references, tables, and figures.
Review papers will be requested by the editors. Review articles are generally prepared in the same format as original articles, but the details of the manuscript format may be flexible according to the contents.
Manuscripts are limited to 5,000 words of text and include a 300 word summary in the place of the unstructured abstract. References should not exceed 100.
CASE REPORTS/IDEAS AND INNOVATIONS
Case reports and ideas and innovations should be unique, that is, never reported or similar to previously reported cases but with unique characteristics related to location, presenting different symptoms, or using a new diagnosis or management modality.
They should include an abstract, introduction, case report(s) or idea(s), discussion, references, tables, and figure legends in that order. They should not exceed 1,500 words, 8 figure pieces, and 20 references. The abstracts should be unstructured and its length should not exceed 200 words.
Book reviews provide a review of newly published book in craniofacial surgery by an invited expert.
CONTINUING MEDICAL EXAMINATION (CME)
CME text is a structured article addressing any educational topic from basic information to the latest trends. It can be related to the special theme of the issue.
This section of the journal is set aside for critical comments directed to a specific article that has recently been published in the journal. Letters should be brief (800 words), double-spaced, and limited to a maximum of 5 citations and 5 figures. The letters and replies should be prepared according to journal format. Illustrative material can be accepted only with the permission of the editor. The authors should include a complete mailing address, telephone and fax numbers, and e-mail address with their correspondence. The editor reserves the right to shorten letters, delete objectionable comments, and make other changes to comply with the style of the journal.
Images notes are short reports of a case or surgical tips. Images should not exceed 200 words and be limited to a maximum of 4 figures. They should not include figure legend and citation.
Texts for the communications section are non-scientific articles that do not follow the structure of a formal journal article. They should address practical concerns or topics that would be of special interest to ACFS readers such as reports on professionallyrelated travel or volunteer work.
This section of the journal is set aside for critical comments directed to a specific article that has recently been published in the journal. Discussions should be brief (800 words), double-spaced, and limited to a maximum of 5 citations and 5 figures. The discussions should be prepared according to journal format. Illustrative material can be accepted only with the permission of the editor. The authors should include a complete mailing address, telephone and fax numbers, and e-mail address with their correspondence. The editor reserves the right to shorten letters, delete objectionable comments, and make other changes to comply with the style of the journal.
Special topics will be determined by the editors. Special topics are generally prepared in the same format as original articles, but the details of the manuscrips format may be flexible according to the contents. Manuscripts are limited to 3,000 words of text and include a 300-word structured abstract. References should not exceed 40.
Manuscripts After Acceptance
Accepted manuscript will be converted to PDF format. The PDF file will be dispatched to the author for proofreading. Any changes should be returned within 48 hours after receipt of the PDF files. No significant changes should be made to alter the interpretation of the results. Only minor changes, such as correcting typographical errors or critical changes to maintain article’s accuracy, are allowed. If there are too many changes during the author’s proofreading process, those changes will not be accepted and the paper can be considered for re-submission. Authors should do their best to ensure the accuracy of the proofs. After the publication, if there are critical errors, they should be corrected as Corrigendumor Erratum.
Publication Processing Charges
For the accepted articles, publication fee will be charged. The basic charge is 200 US dollars (200,000 Korean won), plus 40 US dollars (40,000 Korean won) per page.